Sinonin Biotech GmbH
DEP2716.HRB210521
Firmensitz
Marienstr. 15
27299 Langwedel
Niedersachsen
Deutschland
Kontakt
Geschäftsführung
Seronei Chelulei Cheison
Managing Director
Seit 22. August 2022
Finanzen
| Jahr | Umsatz | Gewinn | Bilanzsumme | Eigenkapitalquote |
|---|---|---|---|---|
| 2024 | ~210.000 € | 0 € | 128.350 € | 33.8% |
| 2023 | ~66.000 € | 0 € | 33.059 € | 77.9% |
| 2022 | ~35.000 € | 0 € | 15.871 € | 50.9% |
Branche
NACE 72.11Forschung und Entwicklung im Bereich BiotechnologieWZ 72.11.0Forschung und Entwicklung im Bereich BiotechnologieISIC 7210Research and experimental development on natural sciences and engineeringNAICS 541713Scientific Research and Development ServicesNAICS 541714Scientific Research and Development ServicesNAICS 541715Scientific Research and Development ServicesUKSIC 72.11Research and experimental development on biotechnologyNACE2025 72.10Forschung und Entwicklung im Bereich Natur-, Ingenieur-, Agrarwissenschaften und Medizin
Rohdaten
{
"id": "00f26cc6-bc19-45d4-b593-c6536e5df15e",
"euId": "DEP2716.HRB210521",
"name": "Sinonin Biotech GmbH",
"legalForm": "GmbH",
"status": "active",
"foundationDate": "2022-08-22T00:00:00",
"vatId": null,
"hq": {
"line2": null,
"street": "Marienstr. 15",
"city": "Langwedel",
"zipCode": "27299",
"state": "NI",
"country": "DE",
"latitude": 52.9744167,
"longitude": 9.1925972
},
"contactData": {
"emails": [],
"phones": [],
"websites": [
"https://www.sinoninbio.tech"
],
"faxes": []
},
"managers": [
{
"name": "Seronei Chelulei Cheison",
"position": "Managing Director",
"startDate": "2022-08-22T00:00:00",
"endDate": null
}
],
"industry": {
"isic": [
"7210"
],
"nace": [
"72.11"
],
"nace2025": [
"72.10"
],
"naics": [
"541713",
"541714",
"541715"
],
"uksic": [
"72.11"
],
"wz": [
"72.11.0"
]
},
"financials": [
{
"year": 2022,
"currency": "EUR",
"capital": 500,
"capitalIsEstimate": false,
"balanceTotal": 15871.03,
"balanceTotalIsEstimate": false,
"earnings": 0,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 35000,
"revenueIsEstimate": true,
"revenueCagr": 0,
"revenueCagrIsEstimate": false,
"returnOnSales": 0,
"returnOnSalesIsEstimate": false,
"equity": 8081.43,
"equityIsEstimate": false,
"equityRatio": 50.919379523572196,
"equityRatioIsEstimate": false,
"cash": 0,
"cashIsEstimate": false,
"receivables": 0,
"receivablesIsEstimate": false,
"liabilities": 3684.72,
"liabilitiesIsEstimate": false
},
{
"year": 2023,
"currency": "EUR",
"capital": 500,
"capitalIsEstimate": false,
"balanceTotal": 33058.87,
"balanceTotalIsEstimate": false,
"earnings": 0,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 66000,
"revenueIsEstimate": true,
"revenueCagr": 88.57142857142857,
"revenueCagrIsEstimate": true,
"returnOnSales": 0,
"returnOnSalesIsEstimate": false,
"equity": 25749.42,
"equityIsEstimate": false,
"equityRatio": 77.88959513740184,
"equityRatioIsEstimate": false,
"cash": 0,
"cashIsEstimate": false,
"receivables": 0,
"receivablesIsEstimate": false,
"liabilities": 1269.57,
"liabilitiesIsEstimate": false
},
{
"year": 2024,
"currency": "EUR",
"capital": 500,
"capitalIsEstimate": false,
"balanceTotal": 128350.22,
"balanceTotalIsEstimate": false,
"earnings": 0,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 210000,
"revenueIsEstimate": true,
"revenueCagr": 144.9489742783178,
"revenueCagrIsEstimate": true,
"returnOnSales": 0,
"returnOnSalesIsEstimate": false,
"equity": 43384.64,
"equityIsEstimate": false,
"equityRatio": 33.801765201493225,
"equityRatioIsEstimate": false,
"cash": 0,
"cashIsEstimate": false,
"receivables": 0,
"receivablesIsEstimate": false,
"liabilities": 26126.67,
"liabilitiesIsEstimate": false
}
]
}